The present invention relates to compounds of formula (I) wherein R1 to R4 and G are as defined in the description and claims and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
申请公布号
CA2630270(A1)
申请公布日期
2007.06.07
申请号
CA20062630270
申请日期
2006.11.20
申请人
F. HOFFMANN-LA ROCHE AG
发明人
RICHTER, HANS;NETTEKOVEN, MATTHIAS;PLANCHER, JEAN-MARC;ROCHE, OLIVIER;TAYLOR, SVEN